MS Management: 4 Things to Know About Relapses

0
(0)

3. How are Relapses Treated?

news_14_Artboard 343 copy 202

Not all patients experiencing relapses need treatment. Some mild sensory alterations, like numbness, pins-and-needle sensations, or peaks of fatigue that don’t interfere with the patient’s normal life are often not treated. However, in the case of severe relapses, such as loss of vision, severe weakness. or poor balance physicians usually recommend treatment. Since the patient’s mobility, safety and overall ability to function are compromised, neurologists may prescribe a short course of high-dose corticosteroids in order to decrease inflammation and end the relapse faster.

The most common course of treatment includes the intravenous administration of Solu-medrol®  (methylprednisolone) or a high dose of oral Deltasone® (prednisone), for three to five days. However, corticosteroids are found ineffective in the long-term treatment of MS. Other treatment options include H.P. Acthar Gel (ACTH) for patients who cannot deal with the side effects of high-dose corticosteroids, for whom corticosteroids are ineffective, who don’t have access to intravenous therapy or who have difficulties receiving medication intravenously, or plasmapheresis (plasma exchange) for the cases that do not respond well to standard steroid treatment.

“Stem cell treatment has been proven to both halt MS clinical relapses and the development of new brain lesions over a prolonged period, according to the results of a new study.”

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
Latest Posts
  • My MS Manager app, Selma blair
  • scans and disability measures
  • Zeke, a MyoPro user
  • MMJ Bioscience study request

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *